A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

March 31, 2014

Conditions
Japanese EncephalitisJapanese Encephalitis Vaccine
Interventions
BIOLOGICAL

Live attenuated Japanese encephalitis vaccine SA14-14-2

Live attenuated Japanese encephalitis vaccine SA14-14-2

Trial Locations (2)

560029

National Institute of Mental Health and Neurosciences, Bangalore

560 012

Indian Institute of Science, Bangalore

All Listed Sponsors
collaborator

National Institute of Mental Health and Neuro Sciences, India

OTHER

collaborator

University of Liverpool

OTHER

collaborator

PATH

OTHER

collaborator

Wellcome Trust

OTHER

lead

Indian Institute of Science

OTHER_GOV

NCT01656200 - A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 | Biotech Hunter | Biotech Hunter